Suppr超能文献

首例为患有遗传性疾病的儿科患者植入经导管无导线起搏器。

First transcatheter leadless pacemaker implantation in a pediatric patient with a genetic disease.

作者信息

Wörmann Jonas, Lüker Jakob, Plenge Tobias, van den Bruck Jan-Hendrik, Steven Daniel, Sultan Arian

机构信息

Department of Electrophysiology, Heart Center, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

出版信息

Herzschrittmacherther Elektrophysiol. 2020 Jun;31(2):235-237. doi: 10.1007/s00399-020-00685-9. Epub 2020 May 5.

Abstract

A pediatric patient suffering from Marden-Walker syndrome, a rare genetic disease, was referred to the authors' hospital for syncope due to bradycardia. Since this disease is associated with severe joint contractures, a transcatheter leadless pacing system (TPS) was chosen. Despite the small body size and complex anatomy, TPS implantation was feasible, demonstrating that it is a safe alternative in difficult venous access compared to a conventional pacemaker with increased risk of lead complications in these patients.

摘要

一名患有罕见遗传病马登-沃克综合征的儿科患者因心动过缓导致晕厥被转诊至作者所在医院。由于该疾病与严重关节挛缩有关,因此选择了经导管无导线起搏系统(TPS)。尽管患者体型小且解剖结构复杂,但TPS植入是可行的,这表明与传统起搏器相比,在这些患者中静脉通路困难时,TPS是一种安全的替代方案,因为传统起搏器存在更高的导线并发症风险。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验